Advertisement

Topics

Merck-Aktie kommt dank Abspaltungsfantasien wieder in die Gänge - Aktienanalyse

01:34 EDT 15 Sep 2017 | FinanzNachrichten

Schwarzach am Main - Merck-Aktienanalyse von "ZertifikateJournal": Die Merck-Aktie (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol: MRK, Nasdaq OTC-Symbol: MKGAF) hat schon bessere Zeiten gesehen, ...

Original Article: Merck-Aktie kommt dank Abspaltungsfantasien wieder in die Gänge - Aktienanalyse

NEXT ARTICLE

More From BioPortfolio on "Merck-Aktie kommt dank Abspaltungsfantasien wieder in die Gänge - Aktienanalyse"

Quick Search
Advertisement
 

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...